Images List Premium Download Classic

Hypertension

Hypertension-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Process for the preparation of kinase inhibitors and intermediates thereof
Aerie Pharmaceuticals, Inc.
July 20, 2017 - N°20170204065

Described are processes for the synthesis of certain compounds, useful for treating diseases, e. G. Eye disease, such as glaucoma and ocular hypertension, in a subject.
Systems and methods for treating pulmonary hypertension
Aria Cv, Inc.
July 20, 2017 - N°20170203020

A system for treating heart disease, such as pulmonary hypertension or right heart failure, including an implantable component and external components for monitoring the implantable component is provided. The implantable component may include a compliant member, e. G., balloon, coupled to a reservoir via a conduit. Preferably, the compliant member is adapted to be implanted in a pulmonary artery and ...
Methods and compositions relating to treatment of pulmonary arterial hypertension
The Brigham And Women's Hospital, Inc.
July 20, 2017 - N°20170202918

The technology described herein is directed to methods and compositions for the treatment of hypertension, e. G. Pulmonary arterial hypertension, relating to inhibition of tgfβ1, tgfβ3, and/or gdf-15.
Hypertension Patent Pack
Download 166+ patent application PDFs
Hypertension Patent Applications
Download 166+ Hypertension-related PDFs
For professional research & prior art discovery
inventor
  • 166+ full patent PDF documents of Hypertension-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Sustained release delivery of active agents to treat glaucoma and ocular hypertension
Mati Therapeutics Inc.
July 20, 2017 - N°20170202853

A method of decreasing intraocular pressure (iop) in an eye of a patient in need thereof includes implanting a first lacrimal implant through a firsts punctum and into a first lacrimal canaliculus of the eye of the patient. The method may further comprise implanting a second lacrimal implant through a second punctum and into a second lacrimal canaliculus of the ...
Water dispersible mini-tablets comprising enalapril for treatment of hypertension in a pediatric population and method ...
Pharmathen S.a.
July 20, 2017 - N°20170202804

The present invention relates to water dispersible mini-tablets of enalapril or a pharmaceutically acceptable salt thereof for use in the treatment of hypertension in a pediatric formulation. The pediatric formulation is defined as 0 to 18 years of age. The present invention also provides a method of manufacturing of such dosage form.
Composition, device, and method for detecting olmesartan and improving compliance in treating hypertension
Autotelic Llc
July 13, 2017 - N°20170199208

This disclosure provides compositions, including antibodies or fragments or derivatives thereof, and related devices and methods effective for detecting and quantifying olmesartan in a sample. The compositions, devices, and methods can be applied to improve the effectiveness of hypertension therapy by monitoring a subject's compliance by determining one or more pharmacokinetic parameters of the subject with a point-of-care device after ...
Hypertension Patent Pack
Download 166+ patent application PDFs
Hypertension Patent Applications
Download 166+ Hypertension-related PDFs
For professional research & prior art discovery
inventor
  • 166+ full patent PDF documents of Hypertension-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Inhibitors of the renal outer medullary potassium channel
Merck Sharp & Dohme Corp.
July 13, 2017 - N°20170197964

The present invention provides compounds of formula i and the pharmaceutically acceptable salts thereof, which are inhibitors of the romk (kir1. 1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt ...
Agonists of the apelin receptor and methods of use thereof
Sanford-burnham Medical Research Institute
July 13, 2017 - N°20170197958

Provided herein are small molecule agonists of the apelin receptor for the treatment of disease. The compounds disclosed herein are useful for the treatment of a range of cardiovascular, renal and metabolic conditions. The present invention is based on the seminal discovery of a series of potent small molecule agonists of the apelin receptor, which are useful for the treatment ...
Conversion of nitrogen dioxide (no2) to nitric oxide (no)
Geno Llc
July 13, 2017 - N°20170197058

Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. A nitric oxide delivery system that converts nitrogen dioxide to nitric oxide employs a surface-active material, such as silica gel, coated with an aqueous solution of antioxidant, such as ascorbic acid.
Cardiovascular disease treatment and prevention
Transdermal Biotechnology, Inc.
July 13, 2017 - N°20170196981

The present invention generally relates to compositions and methods for treatment of subjects having or at risk of arteriosclerosis, hypertension, sickle-cell anemia, or other conditions. In some cases, the composition may include nitric oxide, peptides, or both. The nitric oxide and/or peptide may be present within a first phase comprising a lecithin, such as phosphatidylcholine. In certain embodiments, the ...
Pyridine derivative
Teijin Pharma Limited
July 06, 2017 - N°20170190694

Provided is a pyridine derivative represented by formula (i), a prodrug thereof, a pharmaceutically acceptable salt of the pyridine derivative or the prodrug, or a solvate of the pyridine derivative, the prodrug or the pharmaceutically acceptable salt, which is useful for treatment or prophylaxis of diseases associated with urat1 such as gout, hyperuricemia, hypertension, kidney diseases such as interstitial nephritis, ...
Angiotensinogen (agt) irna compositions and methods of use thereof
Alnylam Pharmaceuticals, Inc.
July 06, 2017 - N°20170189541

The present invention relates to rnai agents, e. G., double-stranded rnai agents, targeting the angiotensinogen (agt) gene, and methods of using such rnai agents to inhibit expression of agt and methods of treating subjects having an agt-associated disorder, e. G., hypertension.
Bacteroides cect 7771 and the use thereof in the prevention and treatment of excess weight, obesity ...
Consejo Superior De Investigaciones Cientificas
July 06, 2017 - N°20170189456

The invention relates to a strain of bacteroides uniformes with registration number cect 7771, and to the cellular constituents, metabolites and/or secreted molecules thereof. The invention also relates to a composition (nutritional or pharmaceutical) comprising at least one of the previous products. The invention further relates to the use of a strain of bacteroides uniforms, preferably cect 7771, or of the ...
Hypertension Patent Pack
Download 166+ patent application PDFs
Hypertension Patent Applications
Download 166+ Hypertension-related PDFs
For professional research & prior art discovery
inventor
  • 166+ full patent PDF documents of Hypertension-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Handheld physiological sensor
Tosense, Inc.
July 06, 2017 - N°20170188875

A handheld device measures all vital signs and some hemodynamic parameters from the human body and transmits measured information wirelessly to a web-based system, where the information can be analyzed by a clinician to help diagnose a patient. The system utilizes our discovery that bio-impedance signals used to determine vital signs and hemodynamic parameters can be measured over a conduction ...
Handheld physiological sensor
Tosense, Inc.
July 06, 2017 - N°20170188873

A handheld device measures all vital signs and some hemodynamic parameters from the human body and transmits measured information wirelessly to a web-based system, where the information can be analyzed by a clinician to help diagnose a patient. The system utilizes our discovery that bio-impedance signals used to determine vital signs and hemodynamic parameters can be measured over a conduction ...
Handheld physiological sensor
Tosense, Inc.
July 06, 2017 - N°20170188859

A handheld device measures all vital signs and some hemodynamic parameters from the human body and transmits measured information wirelessly to a web-based system, where the information can be analyzed by a clinician to help diagnose a patient. The system utilizes our discovery that bio-impedance signals used to determine vital signs and hemodynamic parameters can be measured over a conduction ...
Handheld physiological sensor
Tosense, Inc.
July 06, 2017 - N°20170188849

A handheld device measures all vital signs and some hemodynamic parameters from the human body and transmits measured information wirelessly to a web-based system, where the information can be analyzed by a clinician to help diagnose a patient. The system utilizes our discovery that bio-impedance signals used to determine vital signs and hemodynamic parameters can be measured over a conduction ...
Handheld physiological sensor
Tosense, Inc.
July 06, 2017 - N°20170188844

A handheld device measures all vital signs and some hemodynamic parameters from the human body and transmits measured information wirelessly to a web-based system, where the information can be analyzed by a clinician to help diagnose a patient. The system utilizes our discovery that bio-impedance signals used to determine vital signs and hemodynamic parameters can be measured over a conduction ...
Handheld physiological sensor
Tosense, Inc.
July 06, 2017 - N°20170188843

A handheld device measures all vital signs and some hemodynamic parameters from the human body and transmits measured information wirelessly to a web-based system, where the information can be analyzed by a clinician to help diagnose a patient. The system utilizes our discovery that bio-impedance signals used to determine vital signs and hemodynamic parameters can be measured over a conduction ...
Handheld physiological sensor
Tosense, Inc.
July 06, 2017 - N°20170188842

A handheld device measures all vital signs and some hemodynamic parameters from the human body and transmits measured information wirelessly to a web-based system, where the information can be analyzed by a clinician to help diagnose a patient. The system utilizes our discovery that bio-impedance signals used to determine vital signs and hemodynamic parameters can be measured over a conduction ...
Handheld physiological sensor
Tosense, Inc.
July 06, 2017 - N°20170188829

A handheld device measures all vital signs and some hemodynamic parameters from the human body and transmits measured information wirelessly to a web-based system, where the information can be analyzed by a clinician to help diagnose a patient. The system utilizes our discovery that bio-impedance signals used to determine vital signs and hemodynamic parameters can be measured over a conduction ...
Loading